What Are the Key Takeaways From Rachel Reeves’ Spending Review and Who Will be the Biggest Winners?
Rachel Reeves, the UK’s Chancellor of the Exchequer, has revealed the Government’s Spending Review 2025 (SR25) setting out departmental...
New Horizons: Implications of the UK-India Trade Agreement for Life Sciences and Innovation
The UK and India have announced one of the “biggest and most economically significant” bilateral trade agreements the UK has signed...
One Size Does Not Fit All: EU, UK, and U.S. Regulatory Developments in the Age of Precision Medicine
Advances in precision medicine (also known as “personalized medicine”) have led to an improved understanding of mechanisms underlying...
Venture Capital Secondaries: Exits for Yesterday and Tomorrow
We wanted to follow up on our earlier insights, “Unlocking opportunities: The rise of VC secondaries in democratizing venture capital,”...
Labour Victory: The Implications and Opportunities for Venture Capital and Life Sciences Investments
So, the results are in but what lies ahead for venture capital and life sciences investors following Labour’s victory? Here we share our...
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net